Focus
March 7, 2008

Vamsi MoothaSYSTEMS BIOLOGY: Chemical Toolkit Tests Mitochondria, Reveals Machinery of Drug Effects
A research team led by Vamsi Mootha has developed a chemical toolkit for manipulating mitochondria in their normal cellular environment. After introducing nearly 2,500 compounds to this platform—many of which are FDA approved—the researchers immediately discerned new insights into basic mitochondrial function, which in turn revealed why some commonly used drugs have particular adverse effects. The findings appeared online Feb. 24 in Nature Biotechnology.

Richard HodinGASTROENTEROLOGY: Molecular Defender Disarms Gut Bacteria
Resident bacteria in the intestines help digest food, synthesize essential vitamins, elbow out pathogenic microbes, and direct immune system development. Surgeon-researchers led by Richard Hodin report in the March 4 Proceedings of the National Academy of Sciences that they have a partial molecular explanation for how the body copes with the trillions of bacteria that may be beneficial but could pose a threat. A factor released by the fed gut—but absent from the starving gut—appears to detoxify bacteria in the intestines and may do more to keep them safely confined there.

Zoltan Arany (left) and Bruce SpiegelmanCELL BIOLOGY: Metabolic Regulator Has Hand in Controlling Vessel Growth
Zoltan Arany (left) and Bruce Spiegelman have discovered that a gene known to regulate metabolism, PGC-1 alpha, also coordinates an entire program of new blood vessel construction. In the Feb. 24 Nature, they show that the gene cues several other genes that help build new vessels. Without the gene, new vessels fail to form. Regulating angiogenesis is considered an important but problematic clinical goal for the treatment of a variety of diseases because of the complexity of the process. This new pathway is attractive as a potential therapeutic target because it appears to coordinate a complete angiogenic program.

18th century caricature of dental transplantationPUBLIC HEALTH: The Organ Trade: Right or Wrong?
A symposium at HSPH organized by Daniel Wikler, titled “The Ethics of the Organ Bazaar,” explored the global trade in organs and its benefits and perils. One of the speakers referred to this 18th-century caricature depicting poor people having teeth extracted for a price to fashion dentures for the rich. Similar moral quandaries remain today.

Copyright 2008 by the President and Fellows of Harvard College